Abstract:Bacteriophages offer a promising alternative to conventional antimicrobial treatments, particularly in cases where such treatments have proven ineffective. While naturally occurring phages serve as viable options for phage therapy, advances in synthetic biology and genome engineering enable precise modifications to phages to enhance their therapeutic potential. One such approach is the introduction of antimicrobial genetic payloads into the phage genome. Conventional practice is to integrate such payloads behind genes expressed at very high levels late in the infection cycle, such as the major capsid gene (cps). Nevertheless, phages engineered to contain antimicrobial payloads are often difficult to obtain. For instance, the high expression of toxic payloads can prematurely halt host metabolism, leading to the failure in assembling viable phage progeny. To potentially expand the range of genes viable as genetic payloads, we developed a method to identify intergenic loci with favorable expression levels. We used the machine learning (ML)-based promoter prediction algorithm PhagePromoter to identify these loci. We then used this information to design a computationally-assisted engineering pipeline for the integration of genomic payloads at these locations. We validated our approach experimentally, engineering phages with bioluminescent reporter payloads at various predicted loci. We used the well characterized, strictly lytic, Staphylococcus aureus-infecting bacteriophage, K, as an engineering scaffold and employed homologous recombination to engineer three recombinant phages containing the reporter payload at different predicted loci throughout the genome. The recombinant phages exhibited expression levels consistent with our computational predictions and showed temporal expression patterns corresponding to their genomic locations in early, middle, or late gene clusters. Our study underscores the potential of integrating computational tools with classical sequence analysis to streamline the phage engineering process. This approach not only facilitates the rational design of phages with targeted payload insertions but also paves the way for high-throughput, automated phage engineering, fostering a new era of personalized phage therapy.

An efficient, scarless, selection-free technology for phage engineering

Use of Cas9 Targeting and Red Recombination for Designer Phage Engineering

Utilizing Golden Gate Assembly to Streamline CRISPR-Cas/NgTET-Based Phage Mutagenesis

[Editing of Phage Genomes - Recombineering-Assisted SpCas9 Modification of Model Coliphages T7, T5, and T3]

PHEIGES: all-cell-free phage synthesis and selection from engineered genomes

Repurposing an Endogenous CRISPR-Cas System to Generate and Study Subtle Mutations in Bacteriophages

Engineering bacteriophages for enhanced host range and efficacy: insights from bacteriophage-bacteria interactions

Continuous multiplexed phage genome editing using recombitrons

Recombineering: Genetic Engineering in Escherichia coli Using Homologous Recombination

Computational pipeline for targeted integration and variable payload expression for bacteriophage engineering.

Phage genome engineering with retrons

CRISPR-Cas9 enables efficient genome engineering of the strictly lytic, broad host-range staphylococcal bacteriophage K

Genetic Engineering and Rebooting of Bacteriophages in L-Form Bacteria

Systematic strategies for developing phage resistant Escherichia coli strains

Bacteriophage-resistant industrial fermentation strains: from the cradle to CRISPR/Cas9

Bacterial Genetic Engineering by Means of Recombineering for Reverse Genetics

Cell-free synthesis of infective phages from in vitro assembled phage genomes for efficient phage engineering and production of large phage libraries

CRISPR Gene Editing of a Virulent Bacteriophage

Temporal epigenome modulation enables efficient bacteriophage engineering and functional analysis of phage DNA modifications

A versatile genetic engineering toolkit for E. coli based on CRISPR-prime editing